The Impact of T Cell Vaccination in Alleviating and Regulating Systemic Lupus Erythematosus Manifestation

Table 1

Changes in clinical manifestations and SLEDAI scores of patients with TCV.

Patients	Before TCV		⁢W4		⁢W8		The latest follow-up week
	Clinical features	SLEDAI	Clinical features	SLEDAI	Clinical features	SLEDAI	Clinical features	SLEDAI
P1	Facial and shoulder-back herpes, LC	4	Facial and shoulder-back herpes, LC	2	Facial rash	0	None	0
P2	Facial rash, alopecia, LC	6	Alopecia	2	None	0	None	0
P3	Arthralgia and myalgia, severe ulcer on finger tips, alopecia, LC, relapsing Raynaud’s phenomena in every winter	12	Alopecia, ulcer on finger tips	10	Alopecia	2	No Raynaud’s phenomena this winter	0
P4	Arthralgia, alopecia, LC	6	Alopecia	2	Alopecia, LC	4	None	0
P5	LC, proteinuria	2	LC, proteinuria	2	Proteinuria	0	None	0
P6	Arthralgia, edema, proteinuria, urinary occult blood, LC	10	Proteinuria, LC	6	Urinary occult blood, proteinuria	8	Proteinuria	4
P7	Facial rash, alopecia	6	Alopecia	2	None	0	None	0
P8	LC	5	—	—	LC	2	LC	2
P9	Alopecia, fatigue, myalgia, proteinuria, urinary occult blood, LC	12	Alopecia, proteinuria, LC	8	Alopecia, proteinuria, LC	8	Alopecia, proteinuria	2
P10	Facial rash, arthralgia and myalgia, LC	5	LC	2	LC	2	None	0
P11	Alopecia, arthralgia and myalgia, facial rash, fatigue, lips cyanosis, dyspnea, proteinuria	10	Alopecia, lips cyanosis, dyspnea, proteinuria	2	Alopecia	2	Alopecia	2
P12	Arthralgia, alopecia, edema, fatigue, LC, proteinuria	9	Alopecia, edema LC, proteinuria	8	Alopecia, edema, proteinuria	6	Proteinuria	4
P13	Facial rash, proteinuria, LC	8	Facial rash, proteinuria, LC	6	Facial rash, proteinuria	4	None	0
P14	Facial rash, Raynaud’s phenomena	2	Facial rash, Raynaud’s phenomena	0	Facial rash, Raynaud’s phenomena	0	None	0
P15	Arthralgia, alopecia, LC	4	Alopecia, LC	4	Alopecia	2	None	0
P16	Ulcer of skin on bilateral metacarpophalangeal joints, facial rash, dry mouth and eyes	10	Facial rash, ulcer on knuckle	8	Facial rash, ulcer on knuckle	8	None	0
value

“—” means data absence.